Blood Group Typing Market Overview
Blood Group Typing Market is expected to reach USD 3.9 Billion by 2030 at CAGR 8.9% during the forecast period 2022-2030. The presence and absence of antibodies and genetically determined antigenic compounds on the surface of red blood cells characterize blood group typing. Rising demand for prenatal testing, an increase in traffic accidents, emergencies, and trauma cases requiring blood transfusions, and an increase in blood donations are the key factors driving the blood group typing industry. To safely donate or receive blood transfusions, blood group typing is required. It is also used to see if a person has a substance called Rh factor on their red blood cell surface. There is a strong demand for blood typing goods on the market due to the rising incidence of road accidents and blood transfusions.
Accidents are becoming more common around the world, and the number of cancer patients is rising, increasing the demand for blood transfusions. The increasing prevalence of chronic diseases and expanded R&D initiatives targeted at uncovering the molecular basis of blood and antibody-antigen interactions can be attributed to the PCR sector's large market share and rapid growth. Serology-based diagnostics have seen a greater penetration in poor countries due to the rising usage of assay-based procedures for blood group typing, as well as the comparatively low cost of these tests.
The global blood group typing market has been segmented into technique, test type, product and service, and end user.
The market, by technique, has been segmented into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and others.
The market, by test type, has been segmented into antibody screening, HLA typing, ABO blood tests, cross-matching tests, and antigen typing.
The global market, on the basis of product and service, has been segmented into consumables, instruments, and services. The consumables segment has been segmented into antisera reagents, red blood cells reagents, anti-human globulin reagents, and blood bank saline.
On the basis of end user, the market has been segmented into hospitals, blood banks, clinical laboratories, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The blood group typing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European blood group typing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The blood group typing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The blood group typing market in the Middle East & Africa has been segmented into the Middle East and Africa.
Geographically, the Americas is anticipated to dominate the global blood group typing market owing to a well-developed healthcare sector, rising prevalence of chronic diseases, increasing number of organ transplant, increasing number of blood donations, and presence of different reimbursement schemes for several surgeries. As per the National Kidney Foundation, about 121,678 patients in the US were on the waiting list to receive organs for transplant in 2016.
Europe is expected to hold the second largest position in the global blood group typing market. The market growth in this region is attributed to the rising prevalence of chronic diseases such as cancer along with various Hematological disorders and increasing number of blood transfusion due to road accidents. According to the Office for National Statistics, about 8,208 people were diagnosed with leukemia in England in 2016.
The blood group typing market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in the market due to continuously developing economies, rising prevalence of diseases, growing awareness about blood donations, and increasing government funding for the healthcare sector.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
Global Blood Group Typing Market, by Technique
Global Blood Group Typing Market, by Test Type
Global Blood Group Typing Market, by Product and Service
Global Blood Group Typing Market, by End-User
Global Blood Group Typing Market, by Region
Rest of Europe
Rest of Asia-Pacific
Rest of the World
|Market Size||USD 3.9 Billion|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Technique, Test Type, Product And Service, And End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Bio-Rad Laboratories, Inc., Grifols International, S. A., Beckman Coulter, Immucor, Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, Bag Healthcare GmbH, Rapid Labs, AXO Science, Agena Biosciences, Inc., Day Medical SA, and Merck KGaA|
|Key Market Opportunities||Technological advancements in blood group detections methods|
|Key Market Drivers||
Blood Group Typing Market has the chance to score 8.9% CAGR during the forecast period of 2022 to 2030.
Factors like the increasing number of road accidents, need for blood grouping to decide prenatal testing, rise in blood donations, trauma cases with a requirement for blood transfusion, and inclusion of forensic sciences would inspire better growth for the blood group typing market.
Stringent regulatory procedures can prevent the natural growth of the Blood Group Typing Market.
Blood Group Typing Market has clinical laboratories, blood banks, hospitals, and others as end users.
The Americas would have a maximum Blood Group Typing Market share.